Ever Supreme is approved by the US FDA for conducting clinical trials of allogeneic umbilical cord mesenchymal stem cells on the treatment of new coronavirus

Ever Supreme is approved by the US FDA for conducting clinical trials of allogeneic umbilical cord mesenchymal stem cells on the treatment of new coronavirus

In response to the new coronavirus pandemic, Ever Supreme used allogenic umbilical cord mesenchymal stem cells (UMSC01) to treat the new coronavirus (COVID-19).  Early phase of clinical trial was approved by the US FDA on August of 2020.  Ever Supreme participated in endeavoring as part of the National Team fighting against epidemic.

BACK